Operator
Operator
Good morning and welcome to the Chart Industries 2015 First Quarter Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there will be a question-and-answer session. As a reminder, today's call is being recorded. You should have already received the company's earnings release that was issued earlier this morning. If you have not received the release, you may access it by visiting Chart's website at www.chartindustries.com. A telephone replay of today's broadcast will be available following the conclusion of the call until Thursday, May 7. The replay information is contained in the company's earnings release. Before we begin, the company would like to remind you that statements made during this call that are not historical in fact are forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause actual events or results to differ materially from those expressed or implied in the forward-looking statements. For further information about important factors that could cause actual results to differ materially from those expressed or implied in the forward-looking statements, please refer to the information regarding forward-looking statements and risk factors included in the company's earnings release and latest filings with the SEC. These filings are available through the Investor Relations section of the company's website or through the SEC website, www.sec.gov. The company undertakes no obligation to update publicly or revise any forward-looking statements. I would now like to turn the conference call over to Michael Biehl, Chart Industries' Executive Vice President and CFO. You may begin your conference. Michael F. Biehl - Executive Vice President & Chief Financial Officer: Thank you, Tyrone. Good morning, everyone. I'd like to thank you all for joining us today. Begin by giving you a brief overview of our first quarter results, and then Sam Thomas will provide comments on current market and order trends we see in each of our business segments. I'll then finish up by commenting on our outlook for the remainder of 2015. Net income for the first quarter of 2015 was $5.2 million, or $0.17 per diluted share. This included acquisition-related retention costs as well as Owatonna facility shutdown and other severance costs recorded in the quarter for approximately $900,000, or $0.02 per diluted share. Excluding these items, first quarter 2015 earnings would have been $0.19 per diluted share. This compares with net income of $12 million or $0.38 per diluted share for the first quarter of 2014. First quarter 2014 earnings would have been $0.41 per share excluding $800,000 or $0.02 per diluted share of acquisition-related costs in that period, as well as a $0.01 per diluted share impact associated with Chart's convertible notes. In addition, we had a foreign currency transaction loss of $3.1 million for the first quarter of 2015, or $0.07 per diluted share, as the strength of the U.S. dollar had a significant negative impact on our European operations. We also had foreign currency loss in the first quarter of 2014 but it was relatively small, $100,000. Sales for the quarter were $245.1 million, an 8% decline from the prior-year quarter. This was largely due to a decline in LNG sales in our D&S business, particularly in China. The currency translation had an unfavorable impact as well. Translation effect from the strong dollar reduced revenues about $8 million and gross profit by about $1.9 million in the first quarter of 2015 on a constant currency basis. Our gross profit for the quarter was $72.5 million, or 29.6% of sales, compared with $77.5 million or 29.1% of sales a year ago. Overall margin dollars were down due to lower sales volume in our D&S business, while the gross margin percentage improved due to product mix and lower material costs in D&S, and improved volume and lower warranty costs in our BioMedical business. Orders received in the first quarter totaled $219.5 million were down sequentially from fourth quarter 2014 adjusted orders of $251.7 million, which excludes the $33 million backlog adjustment in China during the fourth quarter of last year. We did see about $4.5 million of order cancellations in our E&C segment in the first quarter of 2015, a consequence of the current energy environment due to lower oil prices. In the E&C business, sales increased 1.5% to $87.5 million for the first quarter of 2015 as lower sales volume in brazed aluminum heat exchangers was more than offset by higher volume in process systems and air cooled heat exchangers. Gross margins were 28.4% in the quarter compared with 28.7% in the prior-year quarter. The negative margin impact of lower brazed aluminum heat exchanger volume was mostly offset by improved execution and project mix of process systems and air cooled heat exchangers. In our D&S business, first quarter sales decreased 19% year-over-year to $105.1 million. Although industrial gas volume increased over the prior-year quarter, lower L&G sales volume globally as well as currency impact on European results more than offset the improvement. Gross margins improved 28.6% compared with 28.1% a year ago due to product mix and lower material costs. In BioMedical, sales increased 4% year-over-year to $52.6 million. This increase was primarily due to higher sales volume in commercial oxygen generation systems. BioMedical gross profit margins improved to 33.5% in the quarter, compared with 32.6% for the same period in 2014 due to higher volume and lower warranty costs associated with respiratory therapy products. SG&A expense for the quarter was $53.2 million, up $2.3 million compared with the same quarter a year ago. The increase was largely due to an acceleration of stock-based compensation expense associated with retirement eligible participants. Under accounting rules, we are required to accelerate expense for employees who are retirement-eligible even if they have not retired. Therefore, first quarter SG&A expense is higher than what we'd expect for the remaining three quarters of 2015. Income tax expense was $2.4 million for the first quarter and represented effective tax rate of 31% compared with $5.2 million for the prior year's quarter, which was an effective tax rate of 29.7%. The increase in the effective tax rate was primarily due to an increased mix of U.S. earnings, which are taxed at a higher rate. I'll now turn the call over to Sam Thomas. Samuel F. Thomas - Chairman, President & Chief Executive Officer: Thank you, Michael, and good morning, everyone. Our first quarter results reflect solid execution across many of our businesses despite the challenges we are facing due to the impact of lower oil pricing and currency headwinds. We continue to take aggressive actions to reduce cost. Over the past several months, we've initiated cost reduction actions, including a head count reduction of 8% of our global workforce, with annualized savings of approximately $30 million. This includes the $20 million of annualized cost savings that we previously disclosed in our February earnings release. We also announced the shutdown of our D&S LNG equipment manufacturing facility in Owatonna, Minnesota due to a slowing of the LNG infrastructure build-out in North America. We're still convinced LNG is compelling as a long-term diesel fuel replacement for high horse power applications such as truck fueling, marine, rail, mining, oil and gas, and power generation. However, consistent with our focus on reducing costs, we believe the decision to close out Owatonna is an appropriate and prudent course of action at this time. We'll continue to service our LNG equipment customers in North America from our other manufacturing facilities. We continue to closely monitor our end markets and order rates and will take additional timely action as we move through the year as necessary. In China, despite weak sales in the first quarter, we continue to see strong order prospects for D&S LNG equipment, and we expect demand to grow as the government continues to pursue its long-standing goal of improving air quality. However, the timing of awards is proving ever-more difficult to call and we are also seeing increased pricing pressure. Overall, as expected, 2015 is going to be a challenging year for Chart. We do expect some growth in our industrial gas and biomedical markets and have significant LNG liquefaction and distribution opportunities that could be larger than any Chart has captured in the past. We do face deteriorating near-term business prospects in the D&S LNG business for applications based on diesel fuel replacement and within E&C for petrochemical, natural gas processing and industrial gas applications. The headwinds associated with low oil prices and the strength of the U.S. dollar are real, the latter impacting the value of our European results in dollar terms. In addition, increased global competition continues to compress E&C pricing and margins. Before I move to talk specifically about each of our businesses, I'd like to emphasize that despite the short-term headwinds we are facing, we remain confident in the long-term fundamental drivers of our growth, including rising industrial production and increased demand for energy globally and natural gas specifically. We're continuing to invest for future growth, including actively pursuing potential acquisition candidates across many of our business segments. Let me now comment on specific highlights for each of our businesses. Within Energy & Chemicals, we booked $43 million in orders during the first quarter, net of order cancellations of approximately $4.5 million that Michael mentioned earlier. This is down sequentially from fourth quarter 2014 orders of $71 million. As reported last quarter, we're facing deteriorating short-term brazed aluminum heat exchanger prospects for petrochemical, natural gas processing and industrial gas applications globally. In addition, the timing of project awards is historically lumpy in the E&C segment and always a challenge to forecast. The 100,000 gallon per day LNG liquefier we delivered to Stabilis in 2014 successfully completed its start-up in the quarter and is now in production, providing LNG for high horse power applications that still benefit from the lower costs and emissions that LNG affords versus diesel. Additionally, both the Noble Energy and LNG Holdings' standard plant liquefiers that we have mentioned in previous calls are scheduled to be up and running later this year. As I alluded to earlier, we're encouraged by the continued interest and quoting activity for small scale LNG liquefaction and larger mid-scale multi-train liquefaction for LNG export facilities here in North America from customers who share our long-term view of the spread between oil and natural gas prices. We've received advanced engineering awards for both Venture Global LNG and Parallax Energy's Live Oak LNG project, both of which, if they go ahead, will employ Chart's IPSMR liquefaction process and proprietary Chart equipment. Parallax Energy also announced their acquisition of the Louisiana LNG project earlier this week, another mid-scale export project that will employ Chart's process technology and equipment. While remaining circumspect with regard to the impact of current oil prices on investment decisions for these projects, we're cautiously optimistic that equipment orders will be forthcoming, perhaps as early as late 2015. Within Distribution & Storage, we booked orders of $124 million in the first quarter, down 4% from our fourth quarter 2014 adjusted orders of $129 million, which takes into account the $33 million backlog adjustment in China during the fourth quarter of 2014. Orders were down primarily due to lower LNG equipment demand for diesel replacement applications in light of the narrow spread between natural gas and diesel. Global industrial gas activity is in line with expectations and should grow in 2014 (sic) [2015] (14:36) based on rising industrial production and major customer forecasts. While LNG orders globally within D&S has slowed, opportunities still exist. We continue to quote significant opportunities for distribution equipment that could result in orders later this year or in 2016. This includes ISO containers for transport on rail cars and ships, in addition to other equipment used in the virtual pipeline. On the topic of LNG for transport, this quarter saw the opening of Shell's first European LNG fueling station in Rotterdam, designed, manufactured and installed by Chart D&S Europe. Chart's scope of supply includes the LNG storage tank, offloading pump skids, control system and LNG dispensers, all supplied to Shell's exacting quality and safety standards. This follows similar openings for Shell and Travel Centers of America truck stop LNG stations in North America, all designed, manufactured and commissioned by Chart. Moving on to BioMedical, orders of $53 million were marginally up compared to the fourth quarter of 2014. Order intake for respiratory and life sciences was as expected. Orders for commercial oxygen systems were up from the prior quarter but still low due to project timing, which is again lumpy. First quarter 2015 results provided further evidence that respiratory therapy demand has stabilized. Orders and revenues have now been consistent for the last three quarters. We still expect to see some growth in the respiratory therapy business in the second half of 2015 as we start to penetrate the China market with a focus on delivering higher-quality products and innovative solutions, a theme that is consistent across all areas of our BioMedical business. Finally, we remain confident that our commercial oxygen system applications will show growth as we move through 2015 on the back of improved product lead times and external customer financing options that we have introduced for waste-water applications. Michael will now provide our outlook for the remainder of 2015. Michael F. Biehl - Executive Vice President & Chief Financial Officer: Thanks, Sam. As we originally anticipated, second half results are expected to be stronger than the first half. Given current business expectations, the company is reaffirming its previously announced sales and earnings guidance. We still expect sales for 2015 to be in a range of $1.05 billion to $1.2 billion and diluted earnings per share expected to be in a range of $1.60 to $2.10 per diluted share on approximately 30.7 million weighted average shares outstanding. This includes the first quarter foreign currency transaction loss of $3.1 million but excludes any restructuring costs and potential dilution impacting – from our convertible notes. With respect to restructuring costs, we anticipate an additional $3 million in costs associated with the Owatonna facility shutdown expected to be recognized in the second quarter, primarily related to the existing lease for this facility. I'd now like to open it up for questions. Tyrone, please provide instructions to the participants to be able to ask questions.